Оrganoprotective efficiency of eprosartan in patients with chronic glomerulonephritis

The 12-week open uncontrollable study of eprosartan organoprotective efficacy was performed in 15 patients with chronic glomerulonephritis. Study results showed high organoprotective efficacy of eprosartan, prescribed in a dose of 600 mg daily, which is expressed as anti-proteinuric, anti-hematuric...

Full description

Bibliographic Details
Main Authors: Ye. V. Kalyuzhina, L. G. Sourkova, M. A. Solovtsov, D. I. Konaplev, V. V. Kalyuzhin
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2007-03-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/3234